| An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer A Araujo, LM Cook, CC Lynch, D Basanta Cancer research 74 (9), 2391-2401, 2014 | 75 | 2014 |
| Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases LCC Cook LM, Shay G, Araujo A Cancer and Metastasis Reviews 33 (2-3), 511-525, 2014 | 73 | 2014 |
| Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer LM Cook, A Araujo, JM Pow-Sang, MM Budzevich, D Basanta, CC Lynch Scientific reports 6 (1), 1-12, 2016 | 41 | 2016 |
| Cancer heterogeneity: converting a limitation into a source of biologic information A Rübben, A Araujo Journal of translational medicine 15 (1), 1-10, 2017 | 27 | 2017 |
| Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling J Gallaher, LM Cook, S Gupta, A Araujo, J Dhillon, JY Park, JG Scott, ... Clinical & experimental metastasis 31 (8), 991-999, 2014 | 24 | 2014 |
| The role of chromosome missegregation in cancer development: a theoretical approach using agent-based modelling A Araujo, B Baum, P Bentley PloS one 8 (8), e72206, 2013 | 14 | 2013 |
| Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer PI Warman, A Kaznatcheev, A Araujo, CC Lynch, D Basanta Games 9 (2), 19, 2018 | 9 | 2018 |
| Size matters: metastatic cluster size and stromal recruitment in the establishment of successful prostate Cancer to bone metastases A Araujo, LM Cook, CC Lynch, D Basanta Bulletin of mathematical biology 80 (5), 1046-1058, 2018 | 9 | 2018 |
| Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement S Hanson, DR Grimes, JP Taylor-King, B Bauer, PI Warman, ... bioRxiv, 049908, 2016 | 7 | 2016 |
| Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor … RU Wahl, M Leijs, A Araujo, A Rübben International journal of molecular sciences 21 (6), 2020 | 4 | 2020 |
| Modelling the Role of Aneuploidy in Tumour Evolution. A Araujo, PJ Bentley, B Baum ALIFE, 488-495, 2010 | 4 | 2010 |
| Testing three hypotheses of the contribution of geometry and migration dynamics to intestine crypt evolution A Araujo, A Rübben, PJ Bentley, D Basanta ALIFE 2018: The 2018 Conference on Artificial Life, 420-427, 2018 | 3 | 2018 |
| Investigating the Origins of Cancer in the Intestinal Crypt with a Gene Network Agent Based Hybrid Model A Araujo, H Zhang, A Rübben, PJ Bentley ALIFE 2019: The 2019 Conference on Artificial Life, 195-202, 2019 | 2 | 2019 |
| Defining the temporal effects of TGFβ inhibition on the cellular heterogeneity of the bone metastatic prostate cancer microenvironment LM Cook, A Araujo, D Basanta, CC Lynch Cancer Research 75 (15 Supplement), 3751-3751, 2015 | 1 | 2015 |
| Optimizing personalized treatment sequences in metastatic castration resistant prostate cancer using tumor-biomarker based computational modeling. S Gupta, J Gallaher, C Lynch, L Cook, A Araujo, J Scott, J Dhillon, ... Journal of Clinical Oncology 33 (15_suppl), e16014-e16014, 2015 | 1 | 2015 |
| Modelling Chromosome Missegregation in Tumour Evolution A Araujo UCL (University College London), 2013 | 1 | 2013 |
| A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with BRAF/MEK-inhibitors evidenced by an algorithm-defined pyrexia score H Schaefer, A Rübben, A Esser, A Araujo, OD Persa, M Leijs medRxiv, 2022 | | 2022 |
| Identification of a specific four-Value Laboratory Signature for BRAF-MEK Inhibitor-induced Pyrexia using a heuristic Agorithm H Schaefer, A Ruebben, M Leijs, A Araujo, A Esser JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 19, 52-52, 2021 | | 2021 |
| Quantification and optimization of standard-of-care therapy to delay the emergence of resistant bone metastatic prostate cancer A Araujo, LM Cook, JS Frieling, W Tan, JA Copland, M Kohli, S Gupta, ... Cancers 13 (4), 677, 2021 | | 2021 |
| Identification of the immunological Response and immunological Side Effects during Immune Checkpoint Inhibitor Therapy of malignant Melanoma by means of correlative Immune and … A Ruebben, RU Wahl, M Leijs, A Araujo JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 18, 54-55, 2020 | | 2020 |
Conor LynchProf. of Tumor Biology, Moffitt Cancer CenterVerified email at moffitt.org
